Clinical Trial Assay & CDx Development in the Era of Precision Medicine – Planning for Success
Dr. Jude O’Donnell discusses Clinicial Trial Assay & CDx Development in the era of Precision Medicine.
Synopsis
- Regulatory considerations for assay development, validation & commercialization
- Choosing the right diagnostic partner: experience, ability to deliver, transparency & trust
- Biomarker-led clinical trial assay and companion diagnostic development & validation challenges
- Case study showcasing a recent Almac Biomarker Program with a large global pharma partner
Diagnostic Services
Your global partner for biomarker discovery, development & commercialisation.
Genomic Services
We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.
Clinical Trial Assays
Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.
Companion Diagnostics
A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialisation services.